Sort by
Refine Your Search
-
Category
-
Country
-
Program
-
Field
-
Postdoctoral Research Fellow – Cancer Cell Cycle Biology and Cancer Epigenetics The Goel Lab at the Peter MacCallum Cancer Centre and The University of Melbourne is seeking applications for a
-
The postdoctoral scholar will have research interests in epigenetic gene regulation, chromatin biology, and nuclear signaling pathways. The laboratory currently uses a yeast model system to define
-
at Birmingham. Job Qualifications: Highly motivated individuals with a Ph.D. degree in genetics, epigenetics, immunology, or cancer biology, as well as the working experience, are strongly encouraged to apply
-
focuses on understanding how epigenetic regulators co-opt with oncogenic transcription factors to drive tumorigenesis, cancer progression and metastasis, and therapeutic resistance. His lab also actively
-
esophageal cancer. The Staff Scientist will be the primary scientist to evaluate mitochondria pathways associated with treatment resistance in esophageal cancer. This project will focus on the epigenetic and
-
for early cancer detection, prognosis, and predictive responses to chemotherapies and targeted drugs. Study the genetic and epigenetic basis of GI cancers (e.g., aberrant DNA methylation, histone
-
future opportunity. Our lab is part of a larger team of scientists within the Department of Immunology dedicated to cutting edge T cell research focused on the epigenetic regulation of T cell effector and
-
structure, and mentoring. Research areas include molecular regulation of metabolism, growth, and body composition; developmental determinants of chronic diseases; epigenetic outcomes of nutritional conditions
-
problems in the biology of aging and cancer. We are particularly interested in the areas of epigenetic regulation, metabolomics and mechanisms of drug resistance. For more information about UVA and the
-
(5ARI) resistance in the context of benign prostatic hyperplasia (BPH) therapy, alongside the identification of clinically relevant epigenetic markers to enhance the efficacy of BPH management